Comparing robot-assisted and open surgery for esophageal cancer
Official title: Clinical Trial Of Safety Of Robot-assisted Thoracic Approach Verus Open Transthoracic Esophagectomy in Esophageal Cancer.
Run by Hospital Universitari de Bellvitge · NCT04652180 · Data updated 2026-11-12
This study is testing if robot-assisted surgery for esophageal cancer is as effective or better than traditional open surgery in helping patients recover and live well after the operation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Hospital Universitari de Bellvitge Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (L'Hospitalet de Llobregat, Barcelona) |
| Status | Recruiting |
| Started | November 6, 2020 |
| Main results expected | December 30, 2025 |
| Study ends | December 30, 2026 |
| Registry record updated | March 1, 2023 |
| Trial ID | NCT04652180 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with histologically confirmed resectable esophageal cancer.
✕Probably not a fit
Patients with advanced stage IV esophageal cancer or those with contraindications for transthoracic esophagectomy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a randomized controlled trial that aims to compare the effectiveness of a robot-assisted thoracic approach to the traditional open transthoracic esophagectomy for patients with resectable esophageal cancer. The study will evaluate postoperative complications, blood loss, hospital stay duration, and overall quality of life following surgery. By analyzing these factors, the trial seeks to determine if the robot-assisted method can provide similar or better oncologic outcomes while reducing complications compared to the standard open approach.
Why it matters
Potential benefit: If successful, this approach could lead to fewer postoperative complications and improved recovery for patients undergoing surgery for esophageal cancer.
How similar studies have gone: Previous studies have shown promising results for minimally invasive techniques in esophageal surgery, suggesting potential benefits of robot-assisted approaches, although this specific comparison is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Histologically proven adenocarcinoma, squamous cell carcinoma, undifferentiated carcinoma or carcinoma of the gastro-esophageal junction (GEJ) Siewert I or II. * Surgical resectable (T1-4a, N0-3, M0). * Childbearing potential women (period between menarche and menopause), pregnancy negative test is mandatory. * Written informed consent. Exclusion Criteria: * Stage IV or GEJ Siewert III esophageal cancer. * Contraindication of transthoracic esophagectomy in two fields. * Pre- or concomitant cancer or conditions which interferes with the study (e.g. prior thoracic surgery or trauma. Rationale: these patients may undergo open resection).
Where it's running
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Natàlia Cornellà, Surgeon
- Email: nataliacornellagcirurgia@gmail.com
- Phone: +34645976556
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Best time for minimally invasive local treatment after first-line systemic therapy for limited (oligo) esophageal or stomach cancer
This trial will test whether giving local treatment (surgery or radiation) earlier or later after first-line systemic therapy works better for people whose esophageal or stomach cancer has spread to only a few sites.
-
Prehabilitation with exercise and nutrition before esophagectomy for esophageal cancer
This program will test if exercise plus nutrition before esophagectomy is doable and acceptable for adults with esophageal cancer.
-
PF-08098488 in adults with advanced solid tumors
This study tests PF-08098488 in adults whose cancer has progressed or returned after prior treatment.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Modular Robot-Assisted Esophagectomy vs. Conventional Minimally Invasive Esophagectomy for Esophageal Cancer
This trial tests whether modular robotic-assisted esophagectomy using the Carina platform works better than conventional 3D thoracoscopic esophagectomy for people with resectable esophageal cancer.
-
MGC030 in adults with advanced solid tumors
This trial tests MGC030 in adults with advanced urothelial, gastric/GEJ, esophageal, colorectal, gastric, pancreatic, or GEJ cancers to see if it is safe and whether it can shrink tumors or stop growth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.